ArcticZymes Technologies ASA

B4V

Company Profile

  • Business description

    ArcticZymes Technologies ASA is a biotechnology company. The company is engaged in developing, producing, and marketing immune-modulating beta-glucans and novel recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. The company's products include Woulgan wound gel, Feed Ingredient (M-Glucan), Nutraceuticals (M-Gard), Recombinant enzymes, and others. The company reports in two operating segments, Enzymes and Corporate. Geographically, it derives a majority of revenue from the USA followed by Lithuania, Germany, Italy, France, and other countries.

  • Contact

    Sykehusveien 23
    Tromso9294
    NOR

    T: +47 77648900

    https://www.arcticzymes.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    53

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,579.9050.100.59%
CAC 407,886.6933.220.42%
DAX 4023,767.4371.840.30%
Dow JONES (US)42,654.74331.990.78%
FTSE 1008,684.5650.810.59%
HKSE23,345.05108.11-0.46%
NASDAQ19,211.1098.780.52%
Nikkei 22537,753.721.79-0.00%
NZX 50 Index12,786.7994.03-0.73%
S&P 5005,958.3841.450.70%
S&P/ASX 2008,343.7046.200.56%
SSE Composite Index3,367.4613.36-0.40%

Market Movers